Suppr超能文献

用于骨关节炎治疗性微小RNA递送的金属有机框架的微流控一步合成法。

Microfluidic one-step synthesis of a metal-organic framework for osteoarthritis therapeutic microRNAs delivery.

作者信息

Yang Kaiyuan, Ni Min, Xu Chao, Wang Liangliang, Han Long, Lv Songwei, Wu Wenbo, Zheng Dong

机构信息

Department of Orthopedics, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.

School of Pharmacy, Changzhou University, Changzhou, China.

出版信息

Front Bioeng Biotechnol. 2023 Jul 27;11:1239364. doi: 10.3389/fbioe.2023.1239364. eCollection 2023.

Abstract

As a class of short non-coding ribonucleic acids (RNAs), microRNAs (miRNA) regulate gene expression in human cells and are expected to be nucleic acid drugs to regulate and treat a variety of biological processes and diseases. However, the issues with potential materials toxicity, quantity production, poor cellular uptake, and endosomal entrapment limit their further applications in clinical practice. Herein, ZIF-8, a metal-organic framework with noncytotoxic zinc (II) as the metal coordination center, was selected as miRNA delivery vector was used to prepare miR-200c-3p@ZIF-8 in one step by Y-shape microfluidic chip to achieve intracellular release with low toxicity, batch size, and efficient cellular uptake. The obtained miR-200c-3p@ZIF-8 was identified by TEM, particle size analysis, XRD, XPS, and zeta potential. Compared with the traditional hydrothermal method, the encapsulation efficiency of miR-200c-3p@ZIF-8 prepared by the microfluidic method is higher, and the particle size is more uniform and controllable. The experimental results in cellular level verified that the ZIF-8 vectors with low cytotoxicity and high miRNAs loading efficiency could significantly improve cellular uptake and endosomal escape of miRNAs, providing a robust and general strategy for nucleic acid drug delivery. As a model, the prepared miR-200c-3p@ZIF-8 is confirmed to be effective in osteoarthritis treatment.

摘要

作为一类短链非编码核糖核酸(RNA),微小RNA(miRNA)可调节人类细胞中的基因表达,并有望成为调节和治疗多种生物过程及疾病的核酸药物。然而,潜在的材料毒性、产量、细胞摄取不佳以及内体截留等问题限制了它们在临床实践中的进一步应用。在此,以具有无细胞毒性的锌(II)作为金属配位中心的金属有机框架ZIF-8作为miRNA递送载体,通过Y形微流控芯片一步制备出miR-200c-3p@ZIF-8,以实现低毒性、批量生产和高效细胞摄取的细胞内释放。通过透射电子显微镜(TEM)、粒度分析、X射线衍射(XRD)、X射线光电子能谱(XPS)和zeta电位对所获得的miR-200c-3p@ZIF-8进行了鉴定。与传统水热法相比,微流控法制备的miR-200c-3p@ZIF-8包封率更高,粒径更均匀且可控。细胞水平的实验结果证实,具有低细胞毒性和高miRNA负载效率的ZIF-8载体可显著提高miRNA的细胞摄取和内体逃逸能力,为核酸药物递送提供了一种强大且通用的策略。作为模型,所制备的miR-200c-3p@ZIF-8被证实对骨关节炎治疗有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a7/10415039/499afa619051/FBIOE_fbioe-2023-1239364_wc_sch1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验